STESTERIS plc
Price
-14%1YEnd-of-day closes, not the intraday tick.
A rare clean sweep: double-check what the checks can't see
Quality strong, no red flags, undemanding price, growing in the filings, the market undecided.
STERIS is a leading global provider of products and services that support patient care with an emphasis on infection prevention. WE HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life science products and services around the globe. We offer our Customers a unique mix of innovative products and services.
In the company’s own words · 10-K filed May 29, 2026 · SEC EDGAR
Charts
As reported to the SEC, without any scoring.
STERIS plc (STE) reported revenue of $1.49B in Q1 2027 (quarter ended Jun 30, 2026), up 7.3% from the same quarter a year earlier. That came with a gross margin of 46% and net income of $200M (13% of revenue). For the full year FY2026, revenue was $5.94B (+8.7% year on year) and net income $782M. Its largest segment in Q1 2027 was Healthcare at $1.05B, 70% of the disclosed total, well ahead of Applied Sterilization Technologies at 20%. The next results filing is expected around Nov 4, 2026, the same week as a year ago.
What the company said
The company's own words from its current reports to the SEC, newest first
- Aug 6, 2026The Original Form 8-K reported that the Board of Directors of the Company (the “Board”) increased its size from nine to ten members on May 5, 2026, and elected Pierre Boulud to serve as a Director effective as of that date.Director or officer change · Form 8-K/A
- Aug 5, 2026On August 5, 2026, the Company announced a targeted consolidation plan (the “Consolidation Plan”) to consolidate existing manufacturing and distribution for formulated chemistries to a new Center of Excellence in North Carolina.Earnings release · Form 8-K
- May 11, 2026STERIS Announces Financial Results for Fiscal 2026 Fourth Quarter and Full Year.Earnings release · press release
Quoted from SEC EDGAR filings. A current report is filed within four business days of the event it describes.
Business segments
Jun 2026 · $1.49BThe company’s own SEC segment disclosure.
- Healthcare$1.05B70%
- Applied Sterilization Technologies$297.6M20%
- Life Science$146.7M10%
Why these answers
Each answer with the checks it was read from. Open one for the numbers.
Conflicts between checks are named, never averaged, and thin data says so.